China Health Industries Holdings, Inc. (CHHE) Revenue (Gross) (2017 - 2023)
China Health Industries Holdings (CHHE) has disclosed Revenue (Gross) for 7 consecutive years, with $26239.0 as the latest value for Q2 2023.
- For the quarter ending Q2 2023, Revenue (Gross) fell 33.0% year-over-year to $26239.0, compared with a TTM value of $26239.0 through Mar 2024, down 79.26%, and an annual FY2023 reading of $113615.0, down 28.03% over the prior year.
- Revenue (Gross) was $26239.0 for Q2 2023 at China Health Industries Holdings, down from $26847.0 in the prior quarter.
- Across five years, Revenue (Gross) topped out at $41034.0 in Q3 2021 and bottomed at $26046.0 in Q4 2022.
- Average Revenue (Gross) over 5 years is $33005.5, with a median of $31952.0 recorded in 2020.
- The sharpest move saw Revenue (Gross) increased 27.82% in 2021, then tumbled 35.84% in 2022.
- Year by year, Revenue (Gross) stood at $31293.0 in 2019, then grew by 9.61% to $34300.0 in 2020, then increased by 18.36% to $40598.0 in 2021, then crashed by 35.84% to $26046.0 in 2022, then increased by 0.74% to $26239.0 in 2023.
- Business Quant data shows Revenue (Gross) for CHHE at $26239.0 in Q2 2023, $26847.0 in Q1 2023, and $26046.0 in Q4 2022.